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ABSTRACT
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis of 
unknown etiology characterized by proliferation of lipid-containing foamy histiocytes 
affecting bones and potentially every organ. There is a wide clinical spectrum of the 
disease, ranging from asymptomatic bone or soft-tissue lesions to life-threatening 
systemic involvement. Although the initial descriptions published by Jakob Erdheim 
and William Chester in 1930 included a patient with right atrial infiltration on autopsy, 
cardiovascular involvement in ECD has only gained more recognition recently. In 
the present report, we describe a case with cardiac involvement, presenting with 
symptomatic heart failure and a cardiac mass assessed with echocardiogram and 
cardiac magnetic resonance imaging.
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CASE REPORT
A 50-year-old female patient, previously asymptomatic, with hypertension, 
type-2 diabetes, chronic kidney disease, and Erdheim-Chester disease 
(ECD) was admitted due to progressive dyspnea (NYHA class III), orthopnea, 
and paroxysmal nocturnal dyspnea, which started one month earlier. ECD 
diagnosis was established seven years earlier after the results of a biopsy of 
a bone lesion in the right tibia. In addition, the patient had been diagnosed 
with retroperitoneal fibrosis and eye xanthogranuloma, both related to ECD, 
and had been treated with prednisone and interferon-α since the diagnosis.
Physical examination upon admission showed basilar pulmonary rales and 
ankle edema. The electrocardiogram (ECG) is shown in Figure 1. Transthoracic 
echocardiography was performed (figure 2) and showed an ejection fraction 
of 47%, eccentric hypertrophy, mild diffuse hypokinesia, thickening of the 
interatrial septum and of the posterior wall of the right atrium, referred as 
lipomatous hypertrophy of the interatrial septum, and a large pericardial 
effusion, without signs of high intrapericardial pressure. The patient showed 
good symptomatic response to beta-blocker, furosemide, isosorbide dinitrate/
hydralazine, and amlodipine and was discharged.
Cardiac magnetic resonance imaging (MRI) was performed (figure 3) 
to assess the left atrium and interatrial septum and showed abnormal soft 
tissue thickening of the posterior wall of the right atrium and of the right 
atrioventricular groove, consistent with cardiac involvement of ECD. In addition, 
there was significant reduction in the volume of the pericardial effusion, most 
likely secondary to the pharmacological treatment of heart failure. Because 
of the typical appearance of the cardiac MRI findings, a cardiac biopsy was 
deemed unnecessary.
DISCUSSION
ECD is a rare non-Langerhans cell histiocytosis of unknown etiology 
characterized by proliferation of lipid-containing foamy histiocytes affecting 
bones and potentially every organ1. The diagnosis is based on the presence 
of symmetric bilateral osteosclerosis of the metaphysis and diaphysis of long 
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bones, and confirmed by histologic examination 
showing foamy histiocytes CD68+, PS100+/-, CD1a-2.
Its broad clinical spectrum ranges from 
asymptomatic bone or soft-tissue lesions to 
life-threatening systemic involvement1. Clinical 
manifestations may be protean and are attributable 
to the functional compromise of organs by histiocytic 
infiltration leading to arterial constriction, which 
results in end-organ atrophy or failure. ECD 
frequently involves the appendicular skeletal 
bones. Therefore, bone pain is the most frequent 
symptom because of the formation of osteosclerotic 
lesions of long bones). This was the case of our 
patient3. Approximately half of patients have extra 
skeletal manifestations, including exophthalmos, 
xanthelasma, interstitial lung disease, retroperitoneal 
fibrosis with perirenal or ureteral obstruction, renal 
failure, diabetes insipidus, and central nervous 
system and cardiovascular involvement4. Although 
the first descriptions published by Jakob Erdheim 
and William Chester in 1930 included a patient with 
right atrial myocardial infiltration on autopsy, only 
recently cardiovascular involvement in ECD started 
to gain more recognition. Originally thought to be 
uncommon, cardiovascular involvement in ECD 
occurs in 40% of cases3. Cardiac manifestations 
of ECD include pericardial infiltration, myocardial 
infiltration, right atrial involvement, and symptomatic 
valvular heart disease. The most common finding 
reported is infiltration of the right heart (49%), 
with approximately 30% of these cases being 
attributed to tumefactive infiltration of the right 
atrium. Other less commonly reported findings 
include atrioventricular sulcus infiltration, pericardial 
effusion (with pericardial thickening), and periarterial 
infiltration of the coronary arteries. More than half 
of patients have periaortic fibrosis5. When the entire 
Figure 1: Twelve-lead ECG showed left atrial and ventricular hypertrophy with secondary repolarization changes.
Figure 2: Transthoracic echocardiography apical 4-chamber 
view showing thickening of the interatrial septum and of the 
posterior wall of the right atrium, referred as lipomatous 
hypertrophy of the interatrial septum.
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aorta is involved, computed tomography (CT) 
may reveal the appearance of a “coated aorta”. 
Infiltration of other arteries may lead to variable 
clinical ischemic manifestations, such as myocardial 
infarction, mesenteric angina, cerebral ischemia, 
and renovascular hypertension3.
ECD has a variable clinical course depending on 
the extent and location of the lesions. Nevertheless, 
this disease may be devastating when there is cardiac 
involvement4. The prognosis is extremely variable 
and is often worse when there is a cardiovascular 
and/or central nervous system involvement2. One 
third of the deaths associated with ECD are caused 
by cardiovascular disease, including heart failure, 
myocardial infarction, cardiac tamponade, and 
aortic occlusion. Therefore, screening for cardiac 
involvement with cardiac MRI or CT imaging in all 
patients diagnosed with ECD, even in the absence of 
cardiac symptoms, has been suggested3. Treatment is 
controversial and it is often based on corticosteroids 
and/or interferon-α2. Interferon-α is currently the first-
line therapy, but its use requires an individualized 
approach4.
The diagnosis of ECD should be entertained in 
all patients with intracardiac and pericardial masses, 
particularly in the right atrium (RA). RA infiltration 
occurs frequently and may cause formation of a 
“pseudotumor”. The differential diagnosis of RA 
masses includes, in order of likelihood, myxoma, 
thrombus, and metastatic and primary malignant 
cardiac tumors3.
Lipomatous hypertrophy of the interatrial septum 
(LHIS) may be defined as a benign cardiac mass 
characterized by 2-cm-thick fatty deposits in the 
interatrial septum6. It encompasses a non-capsulated 
circumscribed, fatty mass and should be considered 
as part of the differential diagnosis for any atrial 
cardiac tumor. In this case report, this was the 
diagnostic hypothesis for the image observed in the 
echocardiogram. Differentiation of LHIS from other 
intracardiac masses is almost always possible using 
conventional imaging techniques, thus limiting the need 
for biopsy and histological conformation6. Because it 
can be mistaken with a malignant tumor, thus leading 
to unwarranted surgical removal, recognition of this 
lesion by different imaging techniques is of paramount 
importance7. Echocardiography is a noninvasive 
method used to diagnose intracardiac tumorous 
lesions, but it is not able to differentiate between fat 
and connective tissue8. Cardiac MRI is considered 
the imaging modality of choice for the assessment of 
cardiac masses. It provides high-quality, multiplanar 
imaging of tumor morphology, tissue composition, 
and perfusion. Additional advantages of cardiac MRI 
are the possibility of assessing cardiac function and 
blood flow, as well as its large field of view making it 
possible to visualize the paracardiac structures and 
the great vessels9.
This case shows an example of the potential 
appearance of cardiac involvement in ECD on 
echocardiographic images. Cardiac MRI is a valuable 
complement of echocardiography that provides tissue 
characterization and shows paracardiac structures 
that may be useful even in patients with a negative 
echocardiogram if cardiac involvement is suspected10.
In summary, in the present report, we described 
a case of ECD with cardiac involvement, presenting 
with symptomatic heart failure and a cardiac mass, 
assessed with echocardiogram and cardiac magnetic 
resonance imaging.
Figure 3: (A) Balanced, steady-state, free-precession, still-frame from 4-chamber view showing abnormal soft tissue 
thickening of the posterior wall of the right atrium (arrow) and of the right atrioventricular groove (*). (B) First-pass 
myocardial perfusion apical 4-chamber view showing less intense myocardial perfusion of the soft tissue thickening in 
comparison with the ventricular myocardium. (C) Late gadolinium enhancement 4-chamber view showing intense and 
mostly peripheral gadolinium enhancement of the abnormal soft tissue thickening in the posterior wall of the right atrium 
and right atrioventricular groove.
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